Targeting tumor acidity pathway may overcome PARP inhibitor resistance in ovarian cancer
Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor resistance in ovarian cancer, one of the most common barriers to the long-term effectiveness of this widely used treatment.
<p>Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor resistance in ovarian cancer, one of the most common barriers to the long-term effectiveness of this widely used treatment.</p>